Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
An overview of potential yields from stablecoins, including yield farming, interest accounts, and risk considerations to optimize income.
27,570 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
SSR Mining just sold its Copler Mine stake for $1.5 billion. This move reshapes its balance sheet, shifts portfolio r...
IBM is quietly reshaping its story with a serious quantum strategy, strong enterprise demand, and a durable dividend....
Two small modular reactor players, NuScale Power and Oklo, are reshaping how utilities think about clean energy. This...
Cerebras' first earnings report brings a clear message for AI stock shoppers: growth alone isn't enough. Here's how t...
Alphabet shifted gears, stepping away from a $346B AI bet to chase faster AI-driven wins. Here’s what that means for ...
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
GM is navigating a tepid U.S. EV market, yet the company is pivoting toward energy storage and software. This article...
Robinhood just announced a substantial $1.5 billion buyback. In this analysis, we weigh the potential benefits agains...
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
As Rivian pivots toward the R2 and scalable production, investors wonder if the company can disrupt market reward in ...
SpaceX is trading far above its IPO price. This article explains what that gain means for early investors, what could...